ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

Cancer Pain Treatment Guide Published By NCCN, ACS

April 27, 2001

Letter From Congress Prompts NCI To Pull Abortion Fact Sheet From Web

July 12, 2002

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007